For example, previous studies have suggested co-activation of RTKs including EGFR and MET in GBM samples [17], we also see high MET expression in RMPAhigh gliomas, with about 5% of the RMPAhigh gliomas harboring MET amplification. The gene discussed is MET; the disease is central nervous system cancer.